Acute Myelogenous Leukemia-Leukemia and Lymphoma Society
About 13,290 Americans are expected to be diagnosed with acute
myelogenous leukemia (AML) in 2008. The chance of getting AML
increases with age. However, children and adults of any age can
develop AML. About one in five children with leukemia has AML.
The goal of treatment for AML is to bring about a remission or
to cure the disease.
The number of patients with AML who enter remission, stay in
remission for years or are cured has increased significantly
over the past 30 years.
AML starts with a change to a single cell in the bone marrow.
With AML, the leukemic cells are often referred to as blast cells.
Medical researchers are working to understand the cell changes that lead to AML.
Down syndrome and other uncommon genetic disorders such as Fanconi anemia and Shwachman-Diamond syndrome and others are associated with an increased risk of AML.
The Leukemia & Lymphoma Society
1311 Mamaroneck Ave.
White Plains, NY 10605
or call the Information Resource Center at (800) 955-4572.